Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-11 | Denali Therapeutics Inc. | Schenkein David P
(Director) |
S | Common Stock | D | 59441 | $32.09 - $32.87 | $1,932,664 |
| 2024-11-11 | Denali Therapeutics Inc. | Schenkein David P
(Director) |
M | Common Stock | A | 47165 | $18.00 - $18.00 | $848,970 |
| 2024-10-18 | Denali Therapeutics Inc. | Watts Ryan J.
(President and CEO) |
S | Common Stock | D | 40000 | $27.69 - $27.69 | $1,107,600 |
| 2024-10-18 | Denali Therapeutics Inc. | Watts Ryan J.
(President and CEO) |
M | Common Stock | A | 40000 | $0.68 - $0.68 | $27,200 |
| 2024-09-30 | Denali Therapeutics Inc. | Krognes Steve E.
(Director) |
S | Common Stock | D | 30000 | $29.03 - $29.03 | $870,900 |
| 2024-09-13 | Denali Therapeutics Inc. | SATO VICKI L
(Director) |
S | Common Stock | D | 1020 | $30.00 - $30.00 | $30,600 |
| 2024-08-20 | Denali Therapeutics Inc. | Watts Ryan J.
(President and CEO) |
S | Common Stock | D | 2260 | $23.79 - $23.79 | $53,765 |
| 2024-08-20 | Denali Therapeutics Inc. | Krognes Steve E.
(Director) |
S | Common Stock | D | 1727 | $23.79 - $23.79 | $41,085 |
| 2024-08-20 | Denali Therapeutics Inc. | Schuth Alexander O.
(COFO and Secretary) |
S | Common Stock | D | 8353 | $23.54 - $24.78 | $200,399 |
| 2024-08-20 | Denali Therapeutics Inc. | Ho Carole
(Chief Medical Officer) |
S | Common Stock | D | 22458 | $23.79 - $24.96 | $549,926 |
| 2024-06-13 | Denali Therapeutics Inc. | Krognes Steve E.
(Director) |
S | Common Stock | D | 30688 | $21.79 - $22.80 | $678,659 |
| 2024-07-01 | Denali Therapeutics Inc. | SATO VICKI L
(Director) |
S | Common Stock | D | 3080 | $22.12 - $22.86 | $68,203 |
| 2024-06-06 | Denali Therapeutics Inc. | Cook Jennifer E.
(Director) |
S | Common Stock | D | 1458 | $21.73 - $21.73 | $31,682 |
| 2024-05-31 | Denali Therapeutics Inc. | Krognes Steve E.
(Director) |
A | Common Stock | A | 5967 | $0.00 - $0.00 | $0 |
| 2024-05-31 | Denali Therapeutics Inc. | Thornberry Nancy
(Director) |
A | Common Stock | A | 5967 | $0.00 - $0.00 | $0 |
| 2024-05-31 | Denali Therapeutics Inc. | Tessier-Lavigne Marc
(Director) |
A | Common Stock | A | 5967 | $0.00 - $0.00 | $0 |
| 2024-05-31 | Denali Therapeutics Inc. | SATO VICKI L
(Director) |
A | Common Stock | A | 5967 | $0.00 - $0.00 | $0 |
| 2024-05-31 | Denali Therapeutics Inc. | Cook Jennifer E.
(Director) |
A | Common Stock | A | 5967 | $0.00 - $0.00 | $0 |
| 2024-05-31 | Denali Therapeutics Inc. | Schenkein David P
(Director) |
A | Common Stock | A | 5967 | $0.00 - $0.00 | $0 |
| 2024-05-31 | Denali Therapeutics Inc. | FLATLEY JAY T
(Director) |
A | Common Stock | A | 5967 | $0.00 - $0.00 | $0 |
| 2024-05-31 | Denali Therapeutics Inc. | Harris Erik
(Director) |
A | Common Stock | A | 5967 | $0.00 - $0.00 | $0 |
| 2024-05-31 | Denali Therapeutics Inc. | Klein Peter S
(Director) |
A | Common Stock | A | 5967 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |